Showing results (381-390 of 572) with videos related to

Sort By:
Pageof 58
Cancer Research Communications|August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology TrialsEsther J Beck, Alexander D Sherry, Marcus A Florez, et al.
JCO Oncology Practice|September 23, 2025
Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical TrialDavid Hui, Ishwaria M Subbiah, David Hong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 7, 2014
BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancerGerald S Falchook, Michael Millward, David Hong, et al.
Journal of Medical Entomology|July 5, 2022
Larvicidal Activity of Two Rutaceae Plant Essential Oils and Their Constituents Against Aedes albopictus (Diptera: Culicidae) in Multiple FormulationsRongchao Jian, Yuan Lin, Yuling Li, et al.
Korean Circulation Journal|January 21, 2026
Genotype-Driven Prognostication in Dilated CardiomyopathyDavid Hong, Young-Gon Kim, Seung Hyeok Bang, et al.
Science Translational Medicine|February 23, 2021
Using viral load and epidemic dynamics to optimize pooled testing in resource-constrained settingsBrian Cleary, James A Hay, Brendan Blumenstiel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settingsBrian Cleary, James A Hay, Brendan Blumenstiel, et al.
Molecular Cancer|February 3, 2025
Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteinsMaria Angelica Freitas-Cortez, Fatemeh Masrorpour, Hong Jiang, et al.
Nature Communications|October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppressionLimo Chen, Don L Gibbons, Sangeeta Goswami, et al.
Lancet (London, England)|July 21, 2023
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trialJoe Y Chang, Steven H Lin, Wenli Dong, et al.
Pageof 58